Stark regional disparities in cancer burden across India
A major cross-sectional analysis from the National Cancer Registry Programme (NCRP) Investigator Group has revealed…
Browsing: Featured
Electronic symptom tracking boosts quality of life for patients on trastuzumab deruxtecan
A new multicentre randomised clinical trial suggests that electronic monitoring of patient-reported outcomes (ePROs) combined…
SAVETHEBOTTOMS!!! Community-based anal cancer screening shows promise for MSM and transgender women
A recent JAMA Surgery study by Welton et al. evaluated the feasibility and acceptability of…
Alcohol and cancer: what clinicians need to know
A recent JAMA Insights article by Morford et al. highlights the strong link between alcohol…
Amino acids: the secret currency of cancer and immunity
Far from being mere cellular building blocks, amino acids have emerged as powerful regulators of…
PD-1 + IL-2 power couple: Wake up ‘sleepy’ T cells to turbo-charge cancer cures
Researchers at Peking Union Medical College Hospital have mapped out why pairing two well-known cancer…
Unusual case of rare ovarian tumour mimicking pregnancy with successful treatment outcome
A new case report was published in Volume 12 of Oncoscience on July 28, 2025, titled A rare…
New gene linked to aggressive, treatment-resistant prostate cancer
A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the…
Overtreatment Factors with Nathan Cherny: An OJC Meets Podcast
Join Christopher Jackson and Nathan Cherny to discuss the overtreatment of patients at the end of life, particularly systemic treatments. An OJC Meets Podcast proudly produced by The Oncology Network.
HRI Scientists investigate new drug to shield breast cancer patients from heart damage
In an Australian first, researchers at the Heart Research Institute (HRI) are using lab-grown ‘mini-hearts’…